Potential impact of annual vaccination with reformulated COVID-19 vaccines: Lessons from the US COVID-19 scenario modeling hub
PLOS Medicine · 2024
DOI: 10.1371/journal.pmed.1004387 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Medicine, 2024. Verfasst von Sung-Mok Jung und 58 weiteren Autor:innen. Beteiligte Einrichtung: University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America. Hauptthemen laut MEDLINE: COVID-19 Vaccines, COVID-19, Hospitalization, SARS-CoV-2. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Background
Coronavirus Disease 2019 (COVID-19) continues to cause significant hospitalizations and deaths in the United States. Its continued burden and the impact of annually reformulated vaccines remain unclear. Here, we present projections of COVID-19 hospitalizations and deaths in the United States for the next 2 years under 2 plausible assumptions about immune escape (20% per year and 50% per year) and 3 possible CDC recommendations for the use of annually reformulated vaccines (no recommendation, vaccination for those aged 65 years and over, vaccination for all eligible age groups based on FDA approval). Methods and findings The COVID-19 Scenario Modeling Hub solicited projections of COVID-19 hospitalization and deaths between April 15, 2023 and April 15, 2025 under 6 scenarios representing the intersection of considered levels of immune escape and vaccination. Annually reformulated vaccines are assumed to be 65% effective against symptomatic infection with strains circulating on June 15 of each year and to become available on September 1. Age- and state-specific coverage in recommended groups was assumed to match that seen for the first (fall 2021) COVID-19 booster. State and national projections from 8 modeling teams were ensembled to produce projections for each scenario and expected reductions in disease outcomes due to vaccination over the projection period. From April 15, 2023 to April 15, 2025, COVID-19 is projected to cause annual epidemics peaking November to January. In the most pessimistic scenario (high immune escape, no vaccination recommendation), we project 2.1 million (90% projection interval (PI) [1,438,000, 4,270,000]) hospitalizations and 209,000 (90% PI [139,000, 461,000]) deaths, exceeding pre-pandemic mortality of influenza and pneumonia. In high immune escape scenarios, vaccination of those aged 65+ results in 230,000 (95% confidence interval (CI) [104,000, 355,000]) fewer hospitalizations and 33,000 (95% CI [12,000, 54,000]) fewer deaths, while vaccination of all eligible individuals results in 431,000 (95% CI: 264,000–598,000) fewer hospitalizations and 49,000 (95% CI [29,000, 69,000]) fewer deaths.
Conclusions
COVID-19 is projected to be a significant public health threat over the coming 2 years. Broad vaccination has the potential to substantially reduce the burden of this disease, saving tens of thousands of lives each year.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
- Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
- The Pennsylvania State University, University Park, Pennsylvania, United States of America.
- University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.
- Fogarty International Center, National Institutes of Health, Bethesda, Maryland, United States of America.
- Northeastern University, Boston, Massachusetts, United States of America.
ORCID-Profile: Sung-Mok Jung, Sara L Loo, Emily Howerton, Lucie Contamin, Claire P Smith, Katie Yan, Samantha J Bents, Jessi Espino, Joseph C Lemaitre, Koji Sato, Clifton D McKee, Alison L Hill, Jessica T Davis, Alessandro Vespignani, Erik T Rosenstrom, Sebastian A Rodriguez-Cartes, Maria E Mayorga, Sean Cavany, Sean M Moore, T Alex Perkins, Shi Chen, Rajib Paul, Jean-Claude Thill, Ajitesh Srivastava, Majd Al Aawar, Shraddha Ramdas Bandekar, Spencer J Fox, Lauren Ancel Meyers, Przemyslaw Porebski, Srini Venkatramanan, Benjamin Hurt, Brian Klahn, Jiangzhuo Chen, Henning Mortveit, Amanda Wilson, Stefan Hoops, Parantapa Bhattacharya, Bryan Lewis, Harry Hochheiser, Michael C Runge, Katriona Shea, Shaun Truelove, Cécile Viboud, Justin Lessler
Förderung
- NIAID NIH HHS
- NIGMS NIH HHS
- NCATS NIH HHS
- NCIRD CDC HHS
- ACL HHS
- Centers for Disease Control and Prevention
- National Science Foundation
- U.S. Department of Health and Human Services
Zitieren
APA
Jung, S. M., Loo, S. L., Howerton, E., Contamin, L., Smith, C. P., Carcelén, E. C., Yan, K., Bents, S. J., Levander, J., Espino, J., Lemaitre, J. C., Sato, K., McKee, C. D., Hill, A. L., Chinazzi, M., Davis, J. T., Mu, K., Vespignani, A., Rosenstrom, E. T., …, & Lessler, J. (2024). Potential impact of annual vaccination with reformulated COVID-19 vaccines: Lessons from the US COVID-19 scenario modeling hub. PLOS Medicine. https://doi.org/10.1371/journal.pmed.1004387
Vancouver
Jung SM, Loo SL, Howerton E, Contamin L, Smith CP, Carcelén EC, et al. Potential impact of annual vaccination with reformulated COVID-19 vaccines: Lessons from the US COVID-19 scenario modeling hub. PLOS Medicine. 2024. doi:10.1371/journal.pmed.1004387
BibTeX
@article{Jung2024,
author = {Jung, Sung-Mok and Loo, Sara L and Howerton, Emily and Contamin, Lucie and Smith, Claire P and Carcelén, Erica C and Yan, Katie and Bents, Samantha J and Levander, John and Espino, Jessi and Lemaitre, Joseph C and Sato, Koji and McKee, Clifton D and Hill, Alison L and Chinazzi, Matteo and Davis, Jessica T and Mu, Kunpeng and Vespignani, Alessandro and Rosenstrom, Erik T and Rodriguez-Cartes, Sebastian A and Ivy, Julie S and Mayorga, Maria E and Swann, Julie L and España, Guido and Cavany, Sean and Moore, Sean M and Perkins, T Alex and Chen, Shi and Paul, Rajib and Janies, Daniel and Thill, Jean-Claude and Srivastava, Ajitesh and Aawar, Majd Al and Bi, Kaiming and Bandekar, Shraddha Ramdas and Bouchnita, Anass and Fox, Spencer J and Meyers, Lauren Ancel and Porebski, Przemyslaw and Venkatramanan, Srini and Adiga, Aniruddha and Hurt, Benjamin and Klahn, Brian and Outten, Joseph and Chen, Jiangzhuo and Mortveit, Henning and Wilson, Amanda and Hoops, Stefan and Bhattacharya, Parantapa and Machi, Dustin and Vullikanti, Anil and Lewis, Bryan and Marathe, Madhav and Hochheiser, Harry and Runge, Michael C and Shea, Katriona and Truelove, Shaun and Viboud, Cécile and Lessler, Justin},
title = {Potential impact of annual vaccination with reformulated COVID-19 vaccines: Lessons from the US COVID-19 scenario modeling hub},
journal = {PLOS Medicine},
year = {2024},
doi = {10.1371/journal.pmed.1004387}
}
EUVIMED